Market Summary
USD65.27+0.65
Market Closed1.01%
LNTH Stock Price
LNTH RSI Chart
LNTH Valuation
LNTH Price/Sales (Trailing)
LNTH Profitability
LNTH Fundamentals
LNTH Revenue
LNTH Earnings
Price Action
52 Week Range
47.46100.85
(Low)(High)
Last 7 days
3.2%
Last 30 days
-1.7%
Last 90 days
-22.8%
Trailing 12 Months
-2%
LNTH Financial Health
LNTH Investor Care
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs
Latest Insider Trading transactions for LNTH
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-09-15 | Niedzwiecki Daniel | acquired | 50,630 | 17.79 | 2,846 | see remarks |
2023-09-15 | Niedzwiecki Daniel | sold | -189,060 | 66.43 | -2,846 | see remarks |
2023-08-29 | Marshall Robert J. Jr. | acquired | - | - | 4,872 | cfo and treasurer |
2023-08-21 | Blanchfield Paul | sold | -26,968 | 66.1 | -408 | president |
2023-08-18 | Blanchfield Paul | sold | -97,785 | 65.19 | -1,500 | president |
2023-08-15 | Marshall Robert J. Jr. | sold | -685,200 | 68.52 | -10,000 | cfo and treasurer |
2023-08-11 | Heino Mary Anne | sold | -750,981 | 68.5828 | -10,950 | ceo |
2023-08-11 | Niedzwiecki Daniel | sold | -291,895 | 67.93 | -4,297 | see remarks |
2023-07-19 | Sabens Andrea | sold | -159,210 | 90.873 | -1,752 | chief accounting officer |
2023-07-18 | Blanchfield Paul | sold (taxes) | -45,273 | 87.4 | -518 | president |
Which funds bought or sold LNTH recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-09-20 | BARCLAYS PLC | reduced | -14.91 | -1,084,000 | 6,935,000 | -% |
2023-09-12 | Prosperity Financial Group, Inc. | added | 6.89 | 18,660 | 234,472 | 0.21% |
2023-09-12 | Farther Finance Advisors, LLC | unchanged | - | 68.00 | 4,196 | -% |
2023-09-08 | TUCKER ASSET MANAGEMENT LLC | new | - | 9,903 | 9,903 | -% |
2023-08-24 | Alberta Investment Management Corp | sold off | -100 | -2,183,220 | - | -% |
2023-08-22 | VIRGINIA RETIREMENT SYSTEMS ET AL | reduced | -32.74 | -438,712 | 948,296 | 0.01% |
2023-08-22 | COMERICA BANK | new | - | - | - | -% |
2023-08-21 | VisionPoint Advisory Group, LLC | new | - | 18,294 | 18,294 | 0.01% |
2023-08-21 | VitalStone Financial, LLC | new | - | 696,000 | 696,000 | 0.39% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -3.77 | -155,002 | 6,936,320 | 0.01% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Schedule 13G FIlings of Lantheus Holdings
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 09, 2023 | vanguard group inc | 10.53% | 7,247,124 | SC 13G/A | |
| Jan 26, 2023 | blackrock inc. | 11.9% | 8,203,470 | SC 13G/A | |
| Jan 20, 2023 | blackrock inc. | 11.9% | 8,203,470 | SC 13G/A | |
| Jul 11, 2022 | vanguard group inc | 10.84% | 7,438,724 | SC 13G/A | |
| Feb 15, 2022 | armistice capital, llc | 0% | 0 | SC 13G/A | |
| Feb 14, 2022 | price t rowe associates inc /md/ | 3.1% | 2,165,371 | SC 13G/A | |
| Feb 04, 2022 | wellington trust co n a | 1.73% | 1,171,449 | SC 13G/A | |
| Jan 27, 2022 | blackrock inc. | 15.8% | 10,675,397 | SC 13G/A | |
| Jan 25, 2022 | blackrock inc. | 15.8% | 10,675,397 | SC 13G | |
| Dec 10, 2021 | wellington management group llp | 4.96% | 3,358,378 | SC 13G/A |
Recent SEC filings of Lantheus Holdings
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Sep 19, 2023 | 4 | Insider Trading | |
| Sep 15, 2023 | 144 | Notice of Insider Sale Intent | |
| Aug 31, 2023 | 4 | Insider Trading | |
| Aug 28, 2023 | 8-K | Current Report | |
| Aug 23, 2023 | 4 | Insider Trading | |
| Aug 22, 2023 | 4 | Insider Trading | |
| Aug 21, 2023 | 144 | Notice of Insider Sale Intent | |
| Aug 18, 2023 | 144 | Notice of Insider Sale Intent | |
| Aug 18, 2023 | 8-K | Current Report | |
| Aug 17, 2023 | 4 | Insider Trading |
Peers (Alternatives to Lantheus Holdings)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
DHR | 182.5B | 30.4B | -3.24% | -5.78% | 28.7 | 6.01 | -1.49% | 0.14% |
ABT | 167.5B | 40.2B | -7.66% | -3.16% | 32.45 | 4.16 | -11.68% | -39.67% |
MDT | 105.0B | 31.6B | -3.94% | -2.93% | 28.96 | 3.33 | 1.57% | -30.40% |
IDXX | 35.9B | 3.5B | -12.23% | 30.55% | 45.38 | 10.22 | 6.21% | 19.20% |
WST | 27.7B | 2.9B | -4.66% | 48.48% | 53.48 | 9.68 | -2.14% | -24.34% |
| MID-CAP | ||||||||
PEN | 9.4B | 937.8M | -2.31% | 34.57% | 323.13 | 10.04 | 16.30% | 250.21% |
LNTH | 4.6B | 1.1B | -1.66% | -2.00% | 136.43 | 4.05 | 69.36% | 3.03% |
NEOG | 4.0B | 822.4M | -18.24% | 27.75% | -175.87 | 4.89 | 56.01% | -147.34% |
QDEL | - | - | -8.05% | -1.80% | - | - | - | - |
| SMALL-CAP | ||||||||
VIVO | 1.5B | 301.6M | 2.29% | 56.91% | -550.1 | 4.93 | -3.75% | -104.51% |
HSKA | 1.2B | 254.9M | 2.45% | 31.18% | -62.25 | 4.89 | -1.22% | 15.74% |
CYRX | 653.5M | 240.7M | -5.45% | -44.20% | -15.31 | 2.72 | 4.82% | 85.44% |
AWH | 45.4M | 9.0M | 55.81% | -7.21% | -2.52 | 5.03 | 20.81% | 50.13% |
QTNT | 766.7K | 37.4M | -50.00% | -99.61% | -0.01 | 0.02 | -2.49% | 10.49% |
Lantheus Holdings News
Returns for LNTH
Cumulative Returns on LNTH
34.4%
7-Year Cumulative Returns
35.0%
5-Year Cumulative Returns
74.9%
3-Year Cumulative Returns
Risks for LNTH
What is the probability of a big loss on LNTH?
89.6%
Probability that Lantheus Holdings stock will be more than 20% underwater in next one year
61.1%
Probability that Lantheus Holdings stock will be more than 30% underwater in next one year.
39.2%
Probability that Lantheus Holdings stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does LNTH drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Lantheus Holdings was unfortunately bought at previous high price.
Drawdowns
Financials for Lantheus Holdings
Income Statement (Last 12 Months)(In Millions)
| Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Revenue | 9.5% | 1,125 | 1,027 | 935 | 801 | 664 | 542 | 425 | 390 | 376 | 341 | 339 | 335 | 332 | 352 | 347 | 344 | 347 | 347 | 343 | 338 | 329 |
| Gross Profit | 12.2% | 594 | 530 | 582 | 472 | 368 | 276 | 188 | 168 | 162 | 142 | 139 | 145 | 150 | 169 | 175 | 174 | 177 | 177 | 175 | 169 | 163 |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | 143 | - | - | - | 123 | - | - | - | 110 | - | - |
| S&GA Expenses | 8.0% | 121 | 113 | 100 | 93.00 | 84.00 | 75.00 | 68.00 | 62.00 | 56.00 | 45.00 | 41.00 | 38.00 | 37.00 | 42.00 | 42.00 | 41.00 | 42.00 | 43.00 | 43.00 | 44.00 | 43.00 |
| R&D Expenses | 0.4% | 331 | 330 | 312 | 51.00 | 49.00 | 47.00 | 45.00 | 46.00 | 47.00 | 39.00 | 33.00 | 25.00 | 18.00 | 19.00 | 20.00 | 20.00 | 20.00 | 18.00 | 17.00 | 16.00 | 16.00 |
| EBITDA | -100.0% | - | 19.00 | 82.00 | 216 | 114 | 21.00 | -25.00 | 9.00 | 19.00 | 37.00 | 23.00 | 22.00 | 29.00 | 45.00 | 56.00 | - | - | - | - | - | - |
| EBITDA Margin | -100.0% | - | 0.02* | 0.09* | 0.27* | 0.17* | 0.04* | -0.06* | 0.02* | 0.05* | 0.11* | 0.07* | 0.07* | 0.09* | 0.13* | 0.16* | - | - | - | - | - | - |
| Interest Expenses | 32.5% | 14.00 | 11.00 | 7.00 | 6.00 | 6.00 | 7.00 | 8.00 | 9.00 | 10.00 | 10.00 | 9.00 | 9.00 | 8.00 | 11.00 | 14.00 | 16.00 | 18.00 | 18.00 | 17.00 | 17.00 | 17.00 |
| Earnings Before Taxes | 145.8% | 19.00 | -42.29 | 27.00 | 162 | 59.00 | -31.48 | -75.04 | -36.87 | -24.50 | -2.67 | -11.48 | -6.24 | 7.00 | 21.00 | 29.00 | 39.00 | 46.00 | 50.00 | 50.00 | 48.00 | 45.00 |
| EBT Margin | 100.0% | - | -0.04* | 0.03* | 0.20* | 0.09* | -0.06* | -0.18* | -0.09* | -0.07* | -0.01* | -0.03* | -0.02* | 0.02* | 0.06* | 0.08* | - | - | - | - | - | - |
| Net Income | 288.5% | 33.00 | -17.70 | 28.00 | 107 | 32.00 | -37.33 | -71.28 | -34.48 | -27.45 | -7.80 | -13.47 | 0.00 | 12.00 | 25.00 | 32.00 | 35.00 | 39.00 | 42.00 | 41.00 | 124 | 124 |
| Net Income Margin | 100.0% | - | -0.02* | 0.03* | 0.13* | 0.05* | -0.07* | -0.17* | -0.09* | -0.07* | -0.02* | -0.04* | 0.00* | 0.04* | 0.07* | 0.09* | - | - | - | - | - | - |
| Free Cashflow | -100.0% | - | 380 | 282 | 190 | 101 | 54.00 | 54.00 | 41.00 | 45.00 | 17.00 | 16.00 | 38.00 | 56.00 | 79.00 | 80.00 | - | - | - | - | - | - |
Balance Sheet(In Millions)
| Balance Sheet | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Assets | -0.9% | 1,338 | 1,349 | 1,321 | 1,096 | 1,014 | 933 | 864 | 848 | 858 | 843 | 870 | 880 | 880 | 404 | 406 | 402 | 390 | 444 | 440 | 425 | 402 |
| Current Assets | -2.7% | 752 | 773 | 678 | 502 | 404 | 325 | 236 | 202 | 186 | 168 | 184 | 185 | 181 | 180 | 173 | 154 | 140 | 195 | 195 | 191 | 167 |
| Cash Equivalents | -12.1% | 414 | 471 | 416 | 257 | 171 | 105 | 101 | 91.00 | 92.00 | 69.00 | 80.00 | 88.00 | 90.00 | 96.00 | 93.00 | 78.00 | 57.00 | 112 | 113 | 105 | 86.00 |
| Inventory | 22.9% | 52.00 | 42.00 | 35.00 | 35.00 | 34.00 | 34.00 | 35.00 | 34.00 | 32.00 | 30.00 | 36.00 | 38.00 | 35.00 | 31.00 | 29.00 | 31.00 | 32.00 | 32.00 | 33.00 | 35.00 | 31.00 |
| Net PPE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 109 | 116 | 114 | 113 | 112 | 108 | 99.00 | 97.00 |
| Goodwill | 0% | 61.00 | 61.00 | 61.00 | 61.00 | 61.00 | 61.00 | 61.00 | 61.00 | 61.00 | 61.00 | 59.00 | 58.00 | 45.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 |
| Liabilities | -13.1% | 785 | 904 | 874 | 458 | 446 | 417 | 399 | 348 | 350 | 315 | 356 | 366 | 364 | 286 | 291 | 301 | 298 | 361 | 369 | 369 | 357 |
| Current Liabilities | -44.3% | 154 | 276 | 248 | 236 | 219 | 178 | 90.00 | 77.00 | 74.00 | 65.00 | 81.00 | 82.00 | 76.00 | 62.00 | 66.00 | 60.00 | 53.00 | 43.00 | 53.00 | 55.00 | 43.00 |
| Long Term Debt | 0.1% | 559 | 559 | 558 | 152 | 156 | 159 | 163 | 167 | 169 | - | 198 | - | - | - | - | - | - | - | - | - | - |
| LT Debt, Current | -9.0% | 0.00 | 0.00 | 0.00 | 15.00 | 14.00 | 13.00 | 12.00 | 10.00 | 10.00 | 10.00 | 21.00 | 18.00 | 17.00 | 10.00 | 10.00 | 10.00 | 10.00 | 3.00 | 3.00 | 3.00 | 3.00 |
| LT Debt, Non Current | - | - | - | 558 | - | - | - | 163 | - | - | 171 | 198 | 205 | 210 | 181 | 184 | 186 | 189 | 263 | 264 | 264 | 265 |
| Shareholder's Equity | 24.0% | 553 | 446 | 447 | 638 | 567 | 516 | 464 | 499 | 508 | 528 | 514 | 514 | 516 | 118 | 115 | 101 | 92.00 | 83.00 | 71.00 | 56.00 | 45.00 |
| Retained Earnings | 48.0% | -101 | -195 | -193 | -73.97 | -135 | -178 | -221 | -181 | -167 | -140 | -149 | -146 | -140 | -133 | -136 | -146 | -151 | -158 | -168 | -181 | -190 |
| Additional Paid-In Capital | 1.8% | 730 | 717 | 716 | 708 | 700 | 692 | 685 | 681 | 676 | 670 | 666 | 662 | 658 | 254 | 252 | 249 | 245 | 242 | 240 | 238 | 236 |
| Shares Outstanding | 0.2% | 70.00 | 70.00 | 69.00 | 69.00 | 69.00 | 68.00 | 68.00 | 68.00 | 68.00 | 67.00 | 67.00 | 67.00 | 43.00 | 39.00 | 39.00 | 39.00 | 39.00 | 39.00 | 39.00 | 38.00 | 38.00 |
Cashflow (Last 12 Months)(In Millions)
| Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Cashflow From Operations | -27.6% | 275 | 380 | 282 | 190 | 101 | 54.00 | 54.00 | 41.00 | 45.00 | 17.00 | 16.00 | 38.00 | 56.00 | 79.00 | 80.00 | 75.00 | 73.00 | 72.00 | 61.00 | 57.00 | 48.00 |
| Share Based Compensation | 15.9% | 39.00 | 33.00 | 29.00 | 25.00 | 21.00 | 18.00 | 16.00 | 15.00 | 16.00 | 14.00 | 14.00 | 13.00 | 13.00 | 13.00 | 12.00 | 12.00 | 11.00 | 10.00 | 9.00 | 9.00 | 8.00 |
| Cashflow From Investing | -5.1% | -336 | -319 | -276 | -16.37 | -12.70 | -11.01 | 4.00 | 4.00 | 3.00 | 11.00 | -4.91 | -5.87 | -5.47 | -14.21 | -22.06 | -24.69 | -26.35 | -28.55 | -19.13 | -17.72 | -16.00 |
| Cashflow From Financing | -0.7% | 303 | 305 | 312 | -8.25 | -8.02 | -6.72 | -39.33 | -41.60 | -47.15 | -52.92 | -21.86 | -20.31 | -14.94 | -81.38 | -78.88 | -76.99 | -76.31 | -5.19 | -4.67 | -2.58 | -2.89 |
| Buy Backs | - | - | - | 75.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LNTH Income Statement
2023-06-30Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
| Income Statement [Abstract] | ||||
| Revenues | $ 321,700 | $ 223,723 | $ 622,484 | $ 432,603 |
| Cost of goods sold | 119,053 | 85,694 | 342,761 | 165,504 |
| Gross profit | 202,647 | 138,029 | 279,723 | 267,099 |
| Operating expenses | ||||
| Sales and marketing | 36,456 | 27,492 | 69,073 | 47,846 |
| General and administrative | 26,151 | 32,598 | 49,422 | 70,186 |
| Research and development | 15,901 | 14,735 | 46,433 | 26,938 |
| Total operating expenses | 78,508 | 74,825 | 164,928 | 144,970 |
| Operating income | 124,139 | 63,204 | 114,795 | 122,129 |
| Interest expense | 4,933 | 1,469 | 9,924 | 2,978 |
| Other income | (4,482) | (310) | (7,713) | (795) |
| Income before income taxes | 123,688 | 62,045 | 112,584 | 119,946 |
| Income tax expense | 29,557 | 18,987 | 21,260 | 33,926 |
| Net income | $ 94,131 | $ 43,058 | $ 91,324 | $ 86,020 |
| Net income per common share: | ||||
| Basic (in dollars per share) | $ 1.38 | $ 0.63 | $ 1.34 | $ 1.26 |
| Diluted (in dollars per share) | $ 1.33 | $ 0.61 | $ 1.31 | $ 1.22 |
| Weighted-average common shares outstanding: | ||||
| Basic (in shares) | 68,371 | 68,674 | 68,062 | 68,343 |
| Diluted (in shares) | 71,014 | 70,796 | 69,957 | 70,412 |
LNTH Balance Sheet
2023-06-30Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
|---|---|---|
| Current assets | ||
| Cash and cash equivalents | $ 414,076 | $ 415,652 |
| Accounts receivable, net | 256,277 | 213,397 |
| Inventory | 51,801 | 35,475 |
| Other current assets | 22,906 | 13,092 |
| Assets held for sale | 7,159 | 0 |
| Total current assets | 752,219 | 677,616 |
| Property, plant and equipment, net | 129,981 | 122,166 |
| Intangibles, net | 221,004 | 315,285 |
| Goodwill | 61,189 | 61,189 |
| Deferred tax assets, net | 134,201 | 110,647 |
| Other long-term assets | 39,126 | 34,355 |
| Total assets | 1,337,720 | 1,321,258 |
| Current liabilities | ||
| Current portion of long-term debt and other borrowings | 384 | 354 |
| Accounts payable | 38,861 | 20,563 |
| Short-term contingent liability | 0 | 99,700 |
| Accrued expenses and other liabilities | 114,798 | 127,084 |
| Total current liabilities | 154,043 | 247,701 |
| Asset retirement obligations | 22,729 | 22,543 |
| Long-term debt, net and other borrowings | 559,235 | 557,712 |
| Other long-term liabilities | 49,068 | 46,155 |
| Total liabilities | 785,075 | 874,111 |
| Commitments and contingencies (See Note 18) | ||
| Stockholders’ equity | ||
| Preferred stock ($0.01 par value, 25,000 shares authorized; no shares issued and outstanding) | 0 | 0 |
| Common stock ($0.01 par value, 250,000 shares authorized; 69,755 and 68,851 shares issued as of June 30, 2023 and December 31, 2022, respectively) | 698 | 689 |
| Additional paid-in capital | 729,733 | 715,875 |
| Treasury Stock at cost - 1,339 shares as of June 30, 2023 and December 31, 2022 | (75,000) | (75,000) |
| Accumulated deficit | (101,834) | (193,158) |
| Accumulated other comprehensive loss | (952) | (1,259) |
| Total stockholders’ equity | 552,645 | 447,147 |
| Total liabilities and stockholders’ equity | $ 1,337,720 | $ 1,321,258 |
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 to detect cardiovascular disease; and Gallium-67 to detect various infections and cancerous tumors. The company also offers AZEDRA, a radiotherapeutic to treat adult and pediatric patients; Automated Bone Scan Index that calculates the disease burden of prostate cancer by quantifying the hotspots on bone scans; and Cobalt (Co 57), a non-pharmaceutical radiochemical; RELISTOR for opioid-induced constipation; and PYLARIFY for visualization of lymph nodes, bone, and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer. It also develops flurpiridaz F 18 to assess blood flow to the heart; 1095, a PSMA-targeted iodine-131 labeled small molecule; LMI 1195 for neuroblastoma tumors in pediatric and adults; PYLARIFY AI, an AI-based medical device software to perform standardized quantitative assessment of PSMA PET/CT images in prostate cancer; and leronlimab, an investigational humanized monoclonal antibody. The company serves radio pharmacies, distributors, integrated delivery networks, hospitals, clinics, and group practices. It has strategic partnerships with NanoMab Technology Limited; Bausch Health Companies, Inc.; GE Healthcare Limited; Curium; Bayer AG; CytoDyn Inc.; ROTOP; FUJIFILM; Regeneron Pharmaceuticals, Inc.; and POINT Biopharma US Inc. The company was founded in 1956 and is headquartered in North Billerica, Massachusetts.